✦ LIBER ✦

Prediction of human pharmacokinetics and tissue distribution of apicidin, a potent histone deacetylase inhibitor, by physiologically based pharmacokinetic modeling

✍ Scribed by Beom Soo Shin; Jürgen B. Bulitta; Joseph P. Balthasar; Minki Kim; Yohan Choi; Sun Dong Yoo

Publisher: Springer
Year: 2010
Tongue: English
Weight: 446 KB
Volume: 68
Category: Article
ISSN: 0344-5704
DOI: 10.1007/s00280-010-1502-y

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pharmacokinetics and tissue distribution

Pharmacokinetics and tissue distribution of Kendine 91, a novel histone deacetylase inhibitor, in mice

✍ Dorleta Otaegui; Alicia Rodríguez-Gascón; Aizpea Zubia; Fernando P. Cossío; José 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 340 KB

Physiologically based pharmacokinetic mo

Physiologically based pharmacokinetic modelling 2: Predicting the tissue distribution of acids, very weak bases, neutrals and zwitterions

✍ Trudy Rodgers; Malcolm Rowland 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 269 KB

A key component of whole body physiologically based pharmacokinetic (WBPBPK) models is the tissue-to-plasma water partition coefficients (Kpu's). The predictability of Kpu values using mechanistically derived equations has been investigated for 7 very weak bases, 20 acids, 4 neutral drugs and 8 zwit

PHRMA CPCDC initiative on predictive mod

PHRMA CPCDC initiative on predictive models of human pharmacokinetics, part 5: Prediction of plasma concentration–time profiles in human by using the physiologically-based pharmacokinetic modeling approach

✍ Patrick Poulin; Rhys D. O. Jones; Hannah M. Jones; Christopher R. Gibson; Malcol 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 529 KB

Rodgers T, Rowland M. 2006. Physiologica

Rodgers T, Rowland M. 2006. Physiologically-based Pharmacokinetic Modeling 2: Predicting the tissue distribution of acids, very weak bases, neutrals and zwitterions. J Pharm Sci 95:1238–1257.

✍ Trudy Rodgers; Malcolm Rowland 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 75 KB

Investigation of 5-FU disposition after

Investigation of 5-FU disposition after oral administration of capecitabine, a triple-prodrug of 5-FU, using a physiologically based pharmacokinetic model in a human cancer xenograft model: comparison of the simulated 5-FU exposures in the tumour tissue between human and xenograft model

✍ Yuko Tsukamoto; Yukio Kato; Masako Ura; Ikuo Horii; Tohru Ishikawa; Hideo Ishits 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 274 KB 👁 2 views

## Abstract The nonlinear pharmacokinetics of capecitabine, a triple prodrug of 5‐FU preferentially activated in tumour tissues, was investigated in human cancer xenograft models. A physiologically based pharmacokinetic (PBPK) model integrating the activation process of capecitabine to 5‐FU and 5‐F

A valid equation for the well-stirred pe

A valid equation for the well-stirred perfusion limited physiologically based pharmacokinetic model that consistently accounts for the blood–tissue drug distribution in the organ and the corresponding valid equation for the steady state volume of distribution

✍ Leonid M. Berezhkovskiy 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 165 KB 👁 1 views

A consistent account of the assumptions of the well-stirred perfusion limited model leads to the equation for the organ tissue that does not coincide with that often presented in books and papers. The difference in pharmacokinetic profiles calculated by the valid and the commonly used equations coul